Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies.

Autor:	Hsu CY; Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan City, 71710, Taiwan.; Thunderbird School of Global Management, Arizona State University Tempe Campus, Phoenix, Arizona, 85004, USA., Faisal A; Department of Pharmacy, Al-Noor University College, Nineveh, Iraq., Jumaa SS; College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq., Gilmanova NS; Department of Prosthetic Dentistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), Russia, Moscow., Ubaid M; Medical Technical College, Al-Farahidi University, Baghdad, Iraq., Athab AH; Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq., Mirzaei R; Venom & Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran., Karampoor S; Gastrointestinal & Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Jazyk:	angličtina
Zdroj:	Non-coding RNA research [Noncoding RNA Res] 2024 May 05; Vol. 9 (3), pp. 970-994. Date of Electronic Publication: 2024 May 05 (Print Publication: 2024).
DOI:	10.1016/j.ncrna.2024.05.001
Abstrakt:	Cancer cells exhibit altered metabolic pathways, prominently featuring enhanced glycolytic activity to sustain their rapid growth and proliferation. Dysregulation of glycolysis is a well-established hallmark of cancer and contributes to tumor progression and resistance to therapy. Increased glycolysis supplies the energy necessary for increased proliferation and creates an acidic milieu, which in turn encourages tumor cells' infiltration, metastasis, and chemoresistance. Circular RNAs (circRNAs) have emerged as pivotal players in diverse biological processes, including cancer development and metabolic reprogramming. The interplay between circRNAs and glycolysis is explored, illuminating how circRNAs regulate key glycolysis-associated genes and enzymes, thereby influencing tumor metabolic profiles. In this overview, we highlight the mechanisms by which circRNAs regulate glycolytic enzymes and modulate glycolysis. In addition, we discuss the clinical implications of dysregulated circRNAs in cancer glycolysis, including their potential use as diagnostic and prognostic biomarkers. All in all, in this overview, we provide the most recent findings on how circRNAs operate at the molecular level to control glycolysis in various types of cancer, including hepatocellular carcinoma (HCC), prostate cancer (PCa), colorectal cancer (CRC), cervical cancer (CC), glioma, non-small cell lung cancer (NSCLC), breast cancer, and gastric cancer (GC). In conclusion, this review provides a comprehensive overview of the significance of circRNAs in cancer glycolysis, shedding light on their intricate roles in tumor development and presenting innovative therapeutic avenues. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu